Smith & Nephew (SNNUF) Net Income towards Common Stockholders (2009 - 2024)
Smith & Nephew (SNNUF) reported Net Income towards Common Stockholders of $253.0 million for Q4 2024, up 19.91% on a YoY basis from $211.0 million in Q1 2024, and up 19.91% quarter-over-quarter from $211.0 million in Q4 2023.
Smith & Nephew (SNNUF) Net Income towards Common Stockholders (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Net Income towards Common Stockholders for 16 years, with the latest figure at $253.0 million in Q4 2024.
- For the quarter ending Q4 2024, Net Income towards Common Stockholders rose 19.91% year-over-year to $253.0 million; the trailing twelve-month figure through Dec 2025 stood at $253.0 million (down 62.13% YoY), and the FY2025 full-year result was $625.0 million, up 51.7% from the prior year.
- Net Income towards Common Stockholders for Q4 2024 stood at $253.0 million, up from $211.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $253.0 million in Q4 2024, with the low at -$34.0 million in Q4 2020.
- Historically, Net Income towards Common Stockholders has averaged $171.4 million across 5 years, with a median of $211.0 million in 2023.
- Annual changes were most pronounced in 2020 — Net Income towards Common Stockholders tumbled 108.88% — and 2021, when it jumped 755.88%.
- Smith & Nephew's Net Income towards Common Stockholders stood at -$34.0 million in 2020, then jumped by 755.88% to $223.0 million in 2021, then dropped by 8.52% to $204.0 million in 2022, then climbed by 3.43% to $211.0 million in 2023, then advanced by 19.91% to $253.0 million in 2024.
- The last three Net Income towards Common Stockholders figures came in at $253.0 million (Q4 2024), $211.0 million (Q4 2023), and $204.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 253.00 Mn |
| Dec 31, 2023 | 211.00 Mn |
| Dec 31, 2022 | 204.00 Mn |
| Dec 31, 2021 | 223.00 Mn |
| Dec 31, 2020 | -34.00 Mn |
| Dec 31, 2019 | 383.00 Mn |
| Dec 31, 2018 | 341.00 Mn |
| Dec 31, 2017 | 383.00 Mn |
| Dec 31, 2016 | 327.00 Mn |
| Dec 31, 2015 | 411.00 Mn |
| Dec 31, 2014 | 1.03 Bn |
| Sep 30, 2014 | 153.00 Mn |
| Mar 31, 2014 | 212.00 Mn |
| Dec 31, 2013 | 204.00 Mn |
| Sep 28, 2013 | 180.00 Mn |
| Jun 29, 2013 | 188.00 Mn |
| Mar 31, 2013 | 232.00 Mn |
| Dec 31, 2012 | 231.00 Mn |
| Sep 29, 2012 | 187.00 Mn |
| Jun 30, 2012 | 475.00 Mn |